Skip to main content
Clinical Trials/RBR-2w55vq
RBR-2w55vq
Recruiting
未知

An epidemiological surveillance study to evaluate the incidence of Dengue in brazil

GlaxoSmithKline Biologicals0 sitesJanuary 6, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Dengue
Sponsor
GlaxoSmithKline Biologicals
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 6, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Written and signed informed consent; male or female at least 6 months of age at the time of enrollment; subject and/or subject’s parent(s) who the investigator believes can comply with the requirements of the protocol and Subject who plans, at the time of enrollment, to remain at same residence/study area during the one year study period

Exclusion Criteria

  • Child in care; participation (current or planned) in another epidemiological study or in a clinical trial that would conflict with the current study, based on investigator’s judgement and terminal illness or severe mental incapacity

Outcomes

Primary Outcomes

Not specified

Similar Trials